Cytokinetics
NasdaqGS:CYTK
$ 65,32
$-0,16 (-0,24%)
65,32 $
$-0,16 (-0,24%)
End-of-day quote: 04/24/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

G
-1,08%
5-year Growth Rate
R
1/6
5-year Risk Analysis
O
4,92%
Outlook 12/26
W
-42,26%
Margin of safety
T
43,14%
Analyst Price Target
H
UP
50-week EMA Trend

Company Info

EPS Growth 5Y
-20,04%
Revenue growth 5Y
-19,17%
Price growth 5Y
142,02%
Market Cap
$8,12 B
Long-Term Debt
$1,12 B
Short Interest
8,57%
Quarterly earnings
05/05/2026
Dividend
$0,00
Dividend Yield
0,00%
Industry
ISIN Number

Cytokinetics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$93,50
43.14%
43.14
Last Update: 04/27/2026
Analysts: 18

Highest Price Target $136,00

Average Price Target $93,50

Lowest Price Target $67,00

Top growth stocks in the health care sector

Stock Rate of Return 5Y Price 5Y Div. 5Y G R O W T H
Cytokinetics
NasdaqGS:CYTK
142,02% 142,02% 0,00% -1,08% 1/6 4,92% -42,26% 43,14% UP
×